コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rylase has little activity on nicotinic acid riboside.
2 ivator 5-aminoimidazole-4-carboxamide-1-beta-riboside.
3 ible on resupplying NAD(+) with nicotinamide riboside.
4 and its metabolite, imidazole-4-acetic acid-riboside.
5 high levels of the O-glucoside of cis-zeatin riboside.
6 4-tetrahydroisoquinoline with 6-chloropurine riboside.
7 agent, 5-aminoimidazole-4-carboxamide (AICA) riboside.
8 O2-methyluridine or 2-pyrimidinone-1-beta-d-riboside.
9 lymerase inhibitor 5,6-dichlorobenzimidazole riboside.
10 n period and the use of the cytokinin zeatin riboside.
11 nicotinamide mononucleotide to nicotinamide riboside.
12 n be converted into analogues of carbocyclic ribosides.
13 n hydrolyze plant hormones such as cytokinin ribosides.
14 , human and mouse A(3)) better than that for ribosides.
16 s precursor viral DNA was sensitive to the L-riboside 1263W94 [5, 6-dichloro-2-(isopropylamino)-1-bet
17 fluorescent probe, 2-aminopurine-2'-O-methyl riboside (2-AP) has been selectively incorporated at ade
18 -isopropylidenetiazofurin (20) or -benzamide riboside (21) followed by hydrolysis and deprotection af
19 >/=90% de and >99% ee) were converted into C-ribosides 29a,b via the Ru-catalyzed ring-closing metath
23 ntains the substrate analogue 6-chloropurine riboside 5'-monophosphate (6-Cl-IMP) and the NAD analogu
26 ars ago, ZTP (5-aminoimidazole-4-carboxamide riboside 5'-triphosphate), a modified purine biosyntheti
27 )] and modified adenosine (2,6-diaminopurine riboside) 5'-triphosphates were incorporated into BRCA1
28 ymerase inhibitor, 5,6-dichlorobenzimidazole riboside (50 micromol/L), did not affect 1alpha, 25-(OH)
31 were inhibited by 5,6-dichlorobenzimidazole riboside, a drug that interferes with the addition of th
34 sue, Belenky et al. report that nicotinamide riboside, a new NAD(+) precursor, regulates Sir2 deacety
35 velopment of steatosis in mice, nicotinamide riboside, a precursor of NAD(+) biosynthesis, was added
36 re of any of these mutants to hydrate purine riboside, a reaction carried out by the wild-type enzyme
37 nalogue, and (6S)-hydroxyl-1,6-dihydropurine riboside, a reaction coordinate analogue, have been dete
38 SMC cultures with 5,6-dichlorobenzimidazole riboside, a selective inhibitor of RNA polymerase II, in
39 r study, 5-amino-imidazolecarboxamide (AICA) riboside, a stimulator of AMP kinase, significantly inhi
40 activation by 5-aminoimidazole-4-carboxamide riboside, A769662 or C13 attenuated Kv 1.5 currents in p
42 nosine analog 5-aminoimidazole-4-carboxamide riboside (AICAR) and inhibition by caffeine and Pfizer c
43 treated with 5-amino-4-imidazole carboxamide riboside (AICAR) for the detection of AMPK phosphorylati
44 by exogenous 5-amino-4-imidazolecarboxamide riboside (AICAr) in a AICAr and MTX concentration-depend
45 tor of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR) inhibited lipopolysaccharide (LPS)-indu
46 of AMPK using 5-aminoimidazole-4-carboxamide riboside (AICAR) inhibited O2-sensitive K+ currents (car
47 ble activator 5-aminoimidazole-4-carboximide riboside (AICAR) is associated with an increase in the o
48 on of AMPK by 5-amino-4-imidazolecarboxamide riboside (AICAR) leads to increased glucose transport.
49 with a pharmacological AMPK activator, AICA-riboside (AICAR) resulted in a time- and concentration-d
50 ative stress, 5-aminoimidazole-4-carboxamide riboside (AICAR), a pharmacological activator of AMPK, i
51 tor, 5-aminoimidazole-4-carboxamide-1-beta-d-riboside (AICAR), activated PYK2, ERK and aPKCs; (b) eff
52 ma cells with 5-aminoimidazole-4-carboxamide riboside (AICAR), an agent that activates AMP-activated
54 ug metformin, 5-aminoimidazole-4-carboxamide riboside (AICAR), and ischemia, well established trigger
55 imetic agent, 5-aminoimidazole-4-carboxamide riboside (AICAR), by the antidiabetic drug phenformin, o
56 tor of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR), inhibited oxidative stress-induced pho
57 K) activator, 5-aminoimidazole-4-carboxamide riboside (AICAR), on tumor necrosis factor alpha (TNF-al
59 vation (using 5-aminoimidazole-4-carboxamide riboside [AICAR]) induces raptor phosphorylation and inh
61 and other aldoses) to give a mixture of four ribosides: alpha and beta pyranosides and furanosides.
62 nicotinamide mononucleotide and nicotinamide riboside also increases NAD(+) levels in astrocytes.
63 stration of 5-aminoimidazole-4-carboxamide-1-riboside also prevented renal hypertrophy, glomerular ba
65 -4-carboxamide 1-beta-d-ribofuranoside (AICA riboside), an activator of AMPK, was tested on denuded o
66 -4-carboxamide-1-beta-D-ribofuranoside (AICA-riboside), an analog of adenosine, is taken up into cell
67 Conversely, 5-aminoimidizole-4-carboxamide riboside, an activator of AMPK, promotes transepithelial
68 at addition of 5-amino-imidazole carboxamide riboside, an AMPK activator, to WGA and human hepatocyte
69 activated by 5-aminoimidazole-4-carboxamide riboside, an AMPK agonist, these data indicate that RNS
70 supplementation of a diet with nicotinamide riboside, an NAD precursor, replenished hepatic NADP and
72 onstrained 2',3'-epoxide derivatives in both riboside and (N)-methanocarba series 13 and 21, respecti
73 ereoselective synthesis of beta-nicotinamide riboside and a series of related amide, ester, and acid
74 K activators 5-amino-4-imidazole carboxamide riboside and A769662 suppressed MMP-9 expression in WT M
75 n by A769662, 5-aminoimidazole-4-carboxamide riboside and C13 and by intracellular dialysis from a pa
76 inhibitors such as 5,6-dichlorobenzimidazole riboside and camptothecin can substantially block VM-26-
77 uman cells, Nrk2 phosphorylates Nicotinamide Riboside and generates NAD+ through an alternative salva
80 Recently, we discovered that nicotinamide riboside and nicotinic acid riboside are biosynthetic pr
84 dichloro-1-beta-D-ribofuranosylbenzimidazole riboside and trastuzumab, but not between inhibitors of
85 the presence of aminoimidazole-4-carboxamide riboside and/or after alpha1AMP-activated protein kinase
86 ated levels of certain purine and pyrimidine ribosides and cytokinins that reflect the substrate pref
87 chloro-1-beta-D-riborfuranosyl benzimidazole riboside) and TCRB (2,5,6-trichloro-1-beta-D-riborfurano
88 o-inositol and IAA-glucan, but not by zeatin riboside, and only weakly by gibberellic acid, abscisic
89 els of nicotinamide riboside, nicotinic acid riboside, and other NAD(+) metabolites were determined b
90 ethylnicotinate riboside, O-methylnicotinate riboside, and several N-alkyl derivatives increased NAD+
92 tors such as 5-amino-imidazole-4-carboxamide riboside, antimycin A, and sodium azide inhibited cell g
93 hat nicotinamide riboside and nicotinic acid riboside are authentic intracellular metabolites in yeas
94 hat nicotinamide riboside and nicotinic acid riboside are biosynthetic precursors of NAD(+), which ar
95 nicotinamide mononucleotide and nicotinamide riboside are reported to confer resistance to metabolic
97 ts reaction with adenosine generated kinetin riboside, as confirmed by comparing the MS/MS profiles o
99 ichloro-1-beta-d-ribofuranosyl benzimidazole riboside (BDCRB) was used to allow the accumulation of h
100 ichloro-1-beta-d-ribofuranosyl benzimidazole riboside (BDCRB) were characterized by nanoparticle trac
101 ichloro-1-beta-d-ribofuranosyl benzimidazole riboside (BDCRB)-treated cultures and purified by tangen
104 mide riboside kinase and that nicotinic acid riboside bioavailability is increased by ester modificat
105 kinase 2 inhibitor 5,6-dichlorobenzimidazole riboside but not, however, by the PI3K inhibitor wortman
106 rd growth conditions, Nrt1, the nicotinamide riboside carrier, is the major AICAr transporter in yeas
107 g actinomycin D or 5,6-dichlorobenzimidazole riboside collagen alpha1(I) mRNA has estimated half-live
108 tions produce predominantly the beta-methoxy riboside compound, with a relative nucleophilicity of Me
110 e activation by aminoimidazole-4-carboxamide riboside counteracted lipopolysaccharide-induced hyperpe
113 growth factor beta, or dichlorobenzimidazole riboside did not result in significant increases in spon
114 he CKII inhibitor, 5,6-dichlorobenzimidazole riboside, did not affect etoposide-stabilized topo II-DN
115 y actinomycin D or 5,6-dichlorobenzimidazole riboside (DRB) causes VHL to be redistributed to the nuc
118 lorie restriction in the mouse, nicotinamide riboside elevates NAD(+) and increases Sir2 function.
120 phenformin or 5-aminoimidazole-4-carboxamide-riboside elicited discrete Ca2+ signaling mechanisms in
121 the Golgi, because 5,6-dichlorobenzimidazole riboside, emetine, and brefeldin A inhibited the increas
122 lementation of yeast cells with nicotinamide riboside extends replicative lifespan and increases Sir2
123 inhibitor platform 5-(formylamino)imidazole riboside (FAIRs, 4) was designed by removal of the-C6(OH
125 ic base pair analogs (inosine, diaminopurine riboside, guanosine, or adenosine paired with U, C, or i
126 imetic AICAR (5-aminoimidazole-4-carboxamide riboside) has been shown to inhibit hepatic gluconeogene
127 se is 100-fold more active as a nicotinamide riboside hydrolase than as a uridine hydrolase and that
128 Hst1, and Rfm1, fully restores nicotinamide riboside import and utilization when resupplied to mutan
131 of AMPK by 5-aminoimidazole-4-carboxamide-1-riboside in OVE26 mice attenuated Nox4 and p53 expressio
132 uptake observed with AMPK activation by AICA-riboside in perfused rat hindlimb muscles is due to an i
133 ue formation of a C-riboside instead of an N-riboside in the condensation of p-aminobenzoic acid (pAB
134 n does not cause a decrease in the CK zeatin riboside in the xylem sap or a strong increase in RMS1 t
135 nistration of 5-aminoimidazole-4-carboxamide riboside in Vasp(-/-) mice reduced hepatic steatosis and
137 8-nitro-1,2,3,4-tetrahydroisoquinolylpurine ribosides, in which the nitrobenzyl moiety in NBMPR has
138 MPK activator 5-aminoimidazole-4-carboxamide-riboside increased AMPK activity twofold and completely
141 ngdom; one preferentially targets the purine ribosides inosine and xanthosine, while the other is mor
142 nthase catalyzes the unique formation of a C-riboside instead of an N-riboside in the condensation of
146 trient in milk, suggesting that nicotinamide riboside is a useful compound for elevation of NAD+ leve
147 xperimentally and revealed that nicotinamide riboside is an unanticipated NAD+ precursor in yeast.
148 uptake observed with AMPK activation by AICA-riboside is due to GLUT4 translocation from an intracell
149 shown that exogenously supplied nicotinamide riboside is imported into yeast cells by a dedicated tra
151 The mechanism of action of nicotinamide riboside is totally dependent on increased net NAD(+) sy
154 tinamide precursor, whereas the nicotinamide riboside kinase 2 (NMRK2) that phosphorylates the nicoti
157 epends on uridine hydrolase and nicotinamide riboside kinase and that nicotinic acid riboside bioavai
158 de elevates NAD+ levels via the nicotinamide riboside kinase pathway and by a pathway initiated by sp
159 sor converted to NAD(+) via the nicotinamide riboside kinase pathway and by nucleosidase activity and
160 se is responsible for mammalian nicotinamide riboside kinase-independent nicotinamide riboside utiliz
164 s with apigenin or 5,6-dichlorobenzimidazole riboside led to a rapid decrease in NKX3.1 accumulation
165 cause current data suggest that nicotinamide riboside may be the only vitamin precursor that supports
166 The adenosine moiety and the nicotinamide riboside moiety are both in the anti conformation about
167 The anti conformation of the nicotinamide riboside moiety is in accord with the preferred conforma
168 of activity, suggesting that the nicotinate riboside moiety is recognized as a neutral zwitterion.
169 ion by NAIM using 5'-O-(1-thio)diaminopurine riboside monophosphate (DMP alphaS), an adenosine analog
170 p into cells and phosphorylated to form AICA-riboside monophosphate (ZMP), which can also activate AM
171 evels of trans-zeatin riboside, trans-zeatin riboside monophosphate and isopentenyladenine 9-glucosid
172 icotinamide riboside (NR) and nicotinic acid riboside (NAR) are the major precursors for NAD biosynth
173 reased the S6-(4-nitrobenzyl)-mercaptopurine riboside (NBMPR) IC50 values by approximately 4- and 6-f
175 th antifolates and nitrobenzylmercaptopurine riboside (NBMPR), a potent inhibitor of the es nucleosid
176 ransporter ligand, nitrobenzylmercaptopurine riboside (NBMPR), designed for probing its bound (bioact
177 cDNA encoding the nitrobenzylmercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside t
180 he simultaneous quantitation of nicotinamide riboside, nicotinamide mononucleotide and NAD in milk by
181 ay, and intracellular levels of nicotinamide riboside, nicotinic acid riboside, and other NAD(+) meta
189 entation with the NAD-precursor nicotinamide riboside (NR) ameliorates energetic derangement and symp
190 e and nicotinic acid as well as nicotinamide riboside (NR) and nicotinic acid riboside (NAR) are the
192 namide mononucleotide (NMN) and nicotinamide riboside (NR) in the amidated salvage pathway despite no
195 lly, deletion of SSY5 increases nicotinamide riboside (NR) levels and phosphate-responsive (PHO) sign
198 liver regeneration, we supplied nicotinamide riboside (NR), an NAD precursor, in the drinking water o
199 inamide mononucleotide (NMN) or nicotinamide riboside (NR), protects against metabolic disease, neuro
204 , nicotinic acid riboside, O-ethylnicotinate riboside, O-methylnicotinate riboside, and several N-alk
205 he trans isomer, although cis-zeatin and its riboside occur as major components in some plant species
209 of AMPK with 5-aminoimidazole-4-carboxamide riboside or salicylate increased nNOS S1412 phosphorylat
210 Furthermore, 5-aminoimidizole-4-carboxamide riboside partially protects the tight junctions from dis
211 t the synthesis of a novel 2'-O-methyl (OMe) riboside phosphoramidite derivative of the G-clamp tricy
212 cue of 8-azaadenosine (pK(a) 2.2) and purine riboside (pK(a) 2.1) interference at A756 at reduced rea
213 y of nucleoside analogs [inosine (I), purine riboside (PR), 2-aminopurine (2-AP), 2,6-diaminopurine (
214 (NMRK2) that phosphorylates the nicotinamide riboside precursor is increased, to a higher level in th
215 tinic acid mononucleotide and nicotinic acid riboside production are also uncovered that further unde
216 y, we discovered that exogenous nicotinamide riboside promotes Sir2-dependent repression of recombina
218 P450 reductase (P450R), dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2), and xanthine o
219 xidoreductase (NQO1) and dihydronicotinamide riboside:quinone oxidoreductases (NQO2) are cytosolic fl
221 sing the inhibitor nitrobenzylmercaptopurine riboside recapitulated the RBV-resistant phenotype in RB
222 ewly identified NAD+ precursor, nicotinamide riboside, reviewed herein, are responsible for vitamin-s
224 rba (i.e., of the Northern conformation) and riboside series 18 and 5, respectively, were potent anta
225 groups that enhance A(3)AR affinity in the 9-riboside series, including those that reduce intrinsic e
228 we present prospects for human nicotinamide riboside supplementation and propose areas for future re
237 ts accumulated higher levels of trans-zeatin riboside, trans-zeatin riboside monophosphate and isopen
242 single gene, YOR071C, abrogates nicotinamide riboside uptake without altering nicotinic acid or nicot
245 Finally, we show that yeast nicotinic acid riboside utilization largely depends on uridine hydrolas
253 chloro-1-beta-D-riborfuranosyl benzimidazole riboside) were the first compounds shown to inhibit clea
254 cleoside phosphorylase cleave nicotinic acid riboside, whereas the yeast phosphorylase has little act
255 fect the bovine milk content of nicotinamide riboside, whereas UHT processing fully destroyed the vit
256 s blocked by 5-amino imidazole-4-carboxamide riboside (which is converted to an AMP-mimetic) or the p
257 ) confers high hydrolase activity for purine ribosides, while an aspartate residue in this position c
258 s also shown to synthesize 2,6-diaminopurine riboside with a catalytic efficiency (1.4 x 10(6) M-1 s-
260 larity of the complex with the dihydropurine riboside with that of an identical complex previously de
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。